AnaptysBio, Inc. (ANAB)
USD 17.16
(5.67%)
USD 17.16
(5.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.15 Million | 10.28 Million | 63.17 Million | 75 Million | 8 Million | 5 Million |
| Cost of Revenue | 2.37 Million | 2.33 Million | 98.49 Million | 80.02 Million | 99.33 Million | 56.19 Million |
| Gross Profit | 14.78 Million | 7.95 Million | -35.32 Million | -5.02 Million | -91.33 Million | -51.19 Million |
| Operating Expenses | 181.56 Million | 125.44 Million | 119.98 Million | 98.87 Million | 115.43 Million | 71.72 Million |
| Selling, General and Administrative Expenses | 41.94 Million | 36.64 Million | 21.49 Million | 18.85 Million | 16.09 Million | 15.52 Million |
| Research and Development Expenses | 132.28 Million | 88.79 Million | 98.49 Million | 80.02 Million | 99.33 Million | 56.19 Million |
| Other Expenses | 7.33 Million | 12 Thousand | 37 Thousand | -11 Thousand | 1000.00 | -159 Thousand |
| Cost and Expenses | 181.56 Million | 125.44 Million | 119.98 Million | 98.87 Million | 115.43 Million | 71.72 Million |
| Operating Income | -164.41 Million | -115.15 Million | -56.81 Million | -23.87 Million | -107.43 Million | -66.72 Million |
| Interest Expense | 18.08 Million | 21.1 Million | 1.45 Million | - | 1.04 Million | 1.65 Million |
| Income Tax Expense | -4000.00 | 24 Thousand | -603 Thousand | -11 Thousand | -152 Thousand | -192 Thousand |
| Earnings before Tax | -163.62 Million | -128.7 Million | -57.79 Million | -19.93 Million | -97.48 Million | -61.84 Million |
| Net Income | -163.61 Million | -128.72 Million | -57.19 Million | -19.92 Million | -97.33 Million | -61.65 Million |
| Earnings Per Share Basic | -6.08 | -4.57 | -2.08 | -0.73 | -3.60 | -2.50 |
| Earnings Per Share Diluted | -6.08 | -4.57 | -2.08 | -0.73 | -3.60 | -2.50 |
| Weighted Average Shares Outstanding | 26.92 Million | 28.16 Million | 27.43 Million | 27.3 Million | 27.05 Million | 24.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.92 Million | 28.16 Million | 27.43 Million | 27.3 Million | 27.05 Million | 24.67 Million |
| Gross Margin | 0.86 | 0.77 | -0.56 | -0.07 | -11.42 | -10.24 |
| EBIT Margin | -8.34 | -10.46 | -0.89 | -0.26 | -12.06 | -12.04 |
| Profit Margin | -9.54 | -12.51 | -0.91 | -0.27 | -12.17 | -12.33 |
| EBITDA | -143.16 Million | -105.25 Million | -55.7 Million | -19.37 Million | -95.93 Million | -59.88 Million |
| Earnings Before Tax Margin | -9.58 | -11.19 | -0.90 | -0.32 | -13.43 | -13.34 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 30.01 Million | 10.97 Million | 7.17 Million | 17.15 Million | 9 Million | 3.31 Million |
| Cost of Revenue | - | 595 Thousand | 605 Thousand | 2.37 Million | 604 Thousand | 592 Thousand |
| Gross Profit | 30.01 Million | 10.37 Million | 6.57 Million | 14.78 Million | 8.4 Million | 2.72 Million |
| Operating Expenses | 52.77 Million | 50.69 Million | 48.77 Million | 174.22 Million | 43.8 Million | 41.05 Million |
| Selling, General and Administrative Expenses | 10.56 Million | 8.85 Million | 11.89 Million | - | 10.27 Million | 10.17 Million |
| Research and Development Expenses | 42.21 Million | 41.84 Million | 36.87 Million | - | 33.52 Million | 30.87 Million |
| Other Expenses | - | - | -2000.00 | -2000.00 | 7.33 Million | 1000.00 |
| Cost and Expenses | 52.77 Million | 51.29 Million | 49.38 Million | 174.22 Million | 43.8 Million | 41.05 Million |
| Operating Income | -22.75 Million | -40.32 Million | -42.2 Million | -164.41 Million | -42.13 Million | -37.73 Million |
| Interest Expense | -15.41 Million | 10.95 Million | 6.31 Million | 18.08 Million | 4.95 Million | 4.43 Million |
| Income Tax Expense | - | 9000.00 | 561.72 Thousand | -4000.00 | 4.87 Million | 4.43 Million |
| Earnings before Tax | -32.85 Million | -46.65 Million | -43.93 Million | -163.62 Million | -42.21 Million | -37.3 Million |
| Net Income | -32.85 Million | -46.66 Million | -43.93 Million | -163.61 Million | -42.21 Million | -37.3 Million |
| Earnings Per Share Basic | -1.14 | -1.71 | -1.64 | - | -1.59 | -1.41 |
| Earnings Per Share Diluted | -1.14 | -1.71 | -1.64 | - | -1.59 | -1.41 |
| Weighted Average Shares Outstanding | 28.89 Million | 27.35 Million | 26.8 Million | 26.92 Million | 26.58 Million | 26.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.89 Million | 27.35 Million | 26.8 Million | 26.92 Million | 26.58 Million | 26.54 Million |
| Gross Margin | 1.00 | 0.95 | 0.92 | 0.86 | 0.93 | 0.82 |
| EBIT Margin | -0.76 | -3.62 | -5.79 | - | -4.07 | -9.73 |
| Profit Margin | -1.09 | -4.25 | -6.12 | -9.54 | -4.69 | -11.24 |
| EBITDA | -22.75 Million | -39.72 Million | -41.59 Million | - | -36.65 Million | -32.28 Million |
| Earnings Before Tax Margin | -0.76 | -3.68 | -5.88 | -9.58 | -4.68 | -11.37 |
SMGI
MELE
PFC
LMTI
3184
GFM